Titre : Mastocytose cutanée

Mastocytose cutanée : Questions médicales fréquentes

Termes MeSH sélectionnés :

REM Sleep Behavior Disorder
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mastocytose cutanée : Questions médicales les plus fréquentes", "headline": "Mastocytose cutanée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mastocytose cutanée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-08-04", "dateModified": "2025-05-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mastocytose cutanée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mastocytose", "url": "https://questionsmedicales.fr/mesh/D008415", "about": { "@type": "MedicalCondition", "name": "Mastocytose", "code": { "@type": "MedicalCode", "code": "D008415", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.762.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mastocytome cutané", "alternateName": "Mastocytoma, Skin", "url": "https://questionsmedicales.fr/mesh/D054705", "about": { "@type": "MedicalCondition", "name": "Mastocytome cutané", "code": { "@type": "MedicalCode", "code": "D054705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.762.750.563.500" } } }, { "@type": "MedicalWebPage", "name": "Urticaire pigmentaire", "alternateName": "Urticaria Pigmentosa", "url": "https://questionsmedicales.fr/mesh/D014582", "about": { "@type": "MedicalCondition", "name": "Urticaire pigmentaire", "code": { "@type": "MedicalCode", "code": "D014582", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.762.750.563.850" } } } ], "about": { "@type": "MedicalCondition", "name": "Mastocytose cutanée", "alternateName": "Mastocytosis, Cutaneous", "code": { "@type": "MedicalCode", "code": "D034701", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Magdalena Lange", "url": "https://questionsmedicales.fr/author/Magdalena%20Lange", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, 80-211 Gdańsk, Poland." } }, { "@type": "Person", "name": "Karin Hartmann", "url": "https://questionsmedicales.fr/author/Karin%20Hartmann", "affiliation": { "@type": "Organization", "name": "Allergologische Poliklinik, Klinik für Dermatologie, Universitätsspital Basel, Petersgraben 4, 4031, Basel, Schweiz. karin.hartmann@usb.ch." } }, { "@type": "Person", "name": "Knut Brockow", "url": "https://questionsmedicales.fr/author/Knut%20Brockow", "affiliation": { "@type": "Organization", "name": "Department of Dermatology and Allergy Biederstein, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany." } }, { "@type": "Person", "name": "Roman J Nowicki", "url": "https://questionsmedicales.fr/author/Roman%20J%20Nowicki", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, 80-211 Gdańsk, Poland." } }, { "@type": "Person", "name": "Olivier Hermine", "url": "https://questionsmedicales.fr/author/Olivier%20Hermine", "affiliation": { "@type": "Organization", "name": "Department of Hematology and Mastocytosis Expert Centre (CEREMAST), Necker Children's Hospital and Paris Descartes University, Assistance Publique Hôpitaux de Paris, Paris, France. Electronic address: ohermine@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evolution of Prodromal REM Sleep Behavior Disorder to Neurodegeneration: A Retrospective Longitudinal Case-Control Study.", "datePublished": "2022-05-12", "url": "https://questionsmedicales.fr/article/35550550", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1212/WNL.0000000000200707" } }, { "@type": "ScholarlyArticle", "name": "REM Behavior Disorder: Implications for PD Therapeutics.", "datePublished": "2023-10-13", "url": "https://questionsmedicales.fr/article/37831394", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11910-023-01310-1" } }, { "@type": "ScholarlyArticle", "name": "Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37233802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00415-023-11785-0" } }, { "@type": "ScholarlyArticle", "name": "Cerebellar Volume Reduction in Patients with Isolated REM Sleep Behavior Disorder: Evidence of a Potential Role of the Cerebellum.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37527632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000533297" } }, { "@type": "ScholarlyArticle", "name": "Cognitive and motor profiles as prodromal markers in predicting phenoconversion and phenotype in isolated REM sleep behavior disorder.", "datePublished": "2023-10-28", "url": "https://questionsmedicales.fr/article/37925853", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2023.10.027" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Troubles de l'activation mastocytaire", "item": "https://questionsmedicales.fr/mesh/D000090362" }, { "@type": "ListItem", "position": 4, "name": "Mastocytose", "item": "https://questionsmedicales.fr/mesh/D008415" }, { "@type": "ListItem", "position": 5, "name": "Mastocytose cutanée", "item": "https://questionsmedicales.fr/mesh/D034701" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mastocytose cutanée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mastocytose cutanée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mastocytose cutanée", "description": "Comment diagnostique-t-on la mastocytose cutanée ?\nQuels tests sont utilisés pour confirmer la mastocytose ?\nLes symptômes sont-ils suffisants pour le diagnostic ?\nLa mastocytose cutanée est-elle confondue avec d'autres maladies ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=REM+Sleep+Behavior+Disorder&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mastocytose cutanée", "description": "Quels sont les symptômes courants de la mastocytose cutanée ?\nLa mastocytose cutanée provoque-t-elle des douleurs ?\nLes symptômes varient-ils d'une personne à l'autre ?\nY a-t-il des symptômes systémiques associés ?\nLes lésions cutanées sont-elles contagieuses ?", "url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=REM+Sleep+Behavior+Disorder&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mastocytose cutanée", "description": "Peut-on prévenir la mastocytose cutanée ?\nLes allergènes peuvent-ils aggraver la condition ?\nFaut-il éviter certains médicaments ?\nL'évitement du stress aide-t-il ?\nLes soins de la peau sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=REM+Sleep+Behavior+Disorder&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mastocytose cutanée", "description": "Quels traitements sont disponibles pour la mastocytose cutanée ?\nLes antihistaminiques sont-ils efficaces ?\nLa photothérapie est-elle une option de traitement ?\nLes traitements sont-ils permanents ?\nDes traitements alternatifs existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=REM+Sleep+Behavior+Disorder&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mastocytose cutanée", "description": "Quelles complications peuvent survenir avec la mastocytose cutanée ?\nLa mastocytose cutanée peut-elle évoluer vers une forme plus grave ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?\nLes complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=REM+Sleep+Behavior+Disorder&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mastocytose cutanée", "description": "Quels sont les facteurs de risque de la mastocytose cutanée ?\nL'âge joue-t-il un rôle dans la mastocytose cutanée ?\nLes femmes sont-elles plus touchées que les hommes ?\nLes maladies auto-immunes augmentent-elles le risque ?\nL'exposition à des produits chimiques est-elle un facteur ?", "url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=REM+Sleep+Behavior+Disorder&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la mastocytose cutanée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et la biopsie cutanée pour détecter les mastocytes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer la mastocytose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins pour mesurer les niveaux de tryptase peuvent être effectués." } }, { "@type": "Question", "name": "Les symptômes sont-ils suffisants pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes doivent être corroborés par des examens histologiques." } }, { "@type": "Question", "name": "La mastocytose cutanée est-elle confondue avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres affections cutanées comme l'urticaire." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des antécédents d'allergies ou d'autres maladies liées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la mastocytose cutanée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des démangeaisons, des rougeurs et des lésions cutanées." } }, { "@type": "Question", "name": "La mastocytose cutanée provoque-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des douleurs localisées, surtout en cas de lésions étendues." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes systémiques comme des nausées peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Les lésions cutanées sont-elles contagieuses ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, les lésions cutanées de la mastocytose ne sont pas contagieuses." } }, { "@type": "Question", "name": "Peut-on prévenir la mastocytose cutanée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique pour la mastocytose cutanée." } }, { "@type": "Question", "name": "Les allergènes peuvent-ils aggraver la condition ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains allergènes peut aggraver les symptômes." } }, { "@type": "Question", "name": "Faut-il éviter certains médicaments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent déclencher des réactions chez les patients sensibles." } }, { "@type": "Question", "name": "L'évitement du stress aide-t-il ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Gérer le stress peut aider à réduire les poussées de symptômes chez certains patients." } }, { "@type": "Question", "name": "Les soins de la peau sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins appropriés de la peau peuvent aider à minimiser les irritations." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la mastocytose cutanée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des antihistaminiques et des corticostéroïdes topiques." } }, { "@type": "Question", "name": "Les antihistaminiques sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à réduire les démangeaisons et les rougeurs." } }, { "@type": "Question", "name": "La photothérapie est-elle une option de traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la photothérapie peut être utilisée pour traiter les lésions cutanées." } }, { "@type": "Question", "name": "Les traitements sont-ils permanents ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, les traitements visent à gérer les symptômes, pas à guérir la maladie." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines personnes explorent des traitements alternatifs, mais leur efficacité n'est pas prouvée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la mastocytose cutanée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections cutanées peuvent survenir en raison de lésions." } }, { "@type": "Question", "name": "La mastocytose cutanée peut-elle évoluer vers une forme plus grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Dans de rares cas, elle peut évoluer vers une mastocytose systémique." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications ne sont pas fréquentes mais peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite souvent une consultation spécialisée." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent affecter la qualité de vie en raison de l'inconfort." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la mastocytose cutanée ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux et des allergies cutanées." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans la mastocytose cutanée ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la mastocytose cutanée est plus fréquente chez les enfants et les jeunes adultes." } }, { "@type": "Question", "name": "Les femmes sont-elles plus touchées que les hommes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Non, la mastocytose cutanée affecte les hommes et les femmes de manière égale." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de mastocytose." } }, { "@type": "Question", "name": "L'exposition à des produits chimiques est-elle un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains produits chimiques peut être un facteur de risque." } } ] } ] }

Sources (10000 au total)

Evolution of Prodromal REM Sleep Behavior Disorder to Neurodegeneration: A Retrospective Longitudinal Case-Control Study.

Individuals with a history of recurrent dream-enactment behaviors, but with subthreshold REM sleep without atonia levels for REM sleep behavior disorder (RBD) diagnosis, are currently classified to ha... This retrospective longitudinal case-control study recruited patients with pRBD and age-matched, sex-matched, and follow-up duration-matched controls who were free of neurodegenerative disease at base... A total of 44 patients (age 67.4 ± 8.2 years, 6 females) and 44 controls were recruited. The combined REM sleep EMG level on mentalis and AT muscles of patients with pRBD significantly increased durin... pRBD has a predictive progression in both pathophysiology and neurodegenerative outcome. This finding has significant implications to the nosological status of pRBD, the current REM sleep-related EMG ... This study provides Class III evidence that EMG activity during REM sleep predicts the development of pRBD....

REM Behavior Disorder: Implications for PD Therapeutics.

Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia that occurs during REM sleep, characterized by REM sleep without atonia (RSWA) and dream enactment behavior (DEB). RBD is associa... Recent research recognizes RBD as a prodromal marker of PD, resulting in expansion of basic science and clinical investigations of RBD. Current basic science research investigates the pathophysiology ...

Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.

Isolated rapid-eye-movement (REM) sleep behavior disorder (iRBD) is considered as a prodromal stage of either multiple system atrophy (MSA) or Lewy body disease (LBD; Parkinson's disease and dementia ... Forty patients with iRBD were enrolled between April 2018 and October 2019 and prospectively followed every 3 months to determine phenoconversion to either MSA or LBD. Plasma NfL levels were measured ... Patients were followed for a median of 2.92 years. Four patients converted to MSA and 7 to LBD. Plasma NfL level at baseline was significantly higher in future MSA-converters (median 23.2 pg/mL) when ... Plasma NfL and cardiac MIBG uptake may be useful biomarkers in predicting phenoconversion of iRBD. Elevated plasma NfL levels may suggest imminent phenoconversion to MSA, whereas low cardiac MIBG upta...

Cerebellar Volume Reduction in Patients with Isolated REM Sleep Behavior Disorder: Evidence of a Potential Role of the Cerebellum.

In this study, we aimed to investigate changes in the total cerebellar volume, subdivisions of the cerebellar volume, and intrinsic cerebellar network in patients with isolated rapid eye movement (REM... We enrolled patients with newly diagnosed iRBD and healthy controls who had no structural lesions according to their brain MRI. All participants underwent three-dimensional T1-weighted imaging. We obt... In total, we enrolled 43 patients with iRBD and 47 healthy controls. Total cerebellar volume in patients with iRBD was lower than that in the healthy controls (8.4637 vs. 9.0863%, p = 0.0001). There w... We found decreased total cerebellar volumes and subdivisions of the cerebellar volume, particularly in the right and left lobule VIIB, in patients with iRBD compared to healthy controls. The present r...

Cognitive and motor profiles as prodromal markers in predicting phenoconversion and phenotype in isolated REM sleep behavior disorder.

To determine the clinical markers based on cognitive and motor profiles in predicting phenoconverion and phenotype in isolated rapid eye movement sleep behavior disorder (iRBD).... 45 iRBD patients and 25 healthy controls were included in the follow-up study. All participates received comprehensive evaluations of cognitive, motor and autonomic function at baseline. Positive phen... 21 iRBD patients displayed phenoconversion in a mean follow-up of 2.9 ± 1.6 years, with 14 presenting motor phenotype and 7 cognitive phenotype. In iRBD, visuospatial, memory, attention-executive func... In iRBD, the attention-executive and motor function served as optimum combined markers in predicting phenoconversion and motor phenotype, whereas the attention-executive function performed best in pre...

Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.

Real-time quaking-induced conversion (RT-QuIC) assay detects misfolded α-synuclein (AS) in the skin and CSF of patients with the synucleinopathies Parkinson disease and dementia with Lewy bodies. Isol... This was a cross-sectional study where consecutive patients with polysomnographic-confirmed IRBD and age-matched controls without RBD underwent skin biopsy and lumbar puncture the same day. Three-mill... We recruited 91 patients with IRBD and 41 controls. In the skin, sensitivity to detect AS was 76.9% (95% CI 66.9-85.1), specificity 97.6% (95% CI 87.1-99.9) positive predictive value 98.6% (95% CI 91.... Our study in IRBD shows that (1) RT-QuIC detects AS in the skin and CSF with similar high sensitivity, specificity, and agreement, (2) AS RT-QuIC positivity is associated with supportive features and ... This study provides Class III evidence that RT-QuIC-detected AS in the skin and CSF distinguishes patients with IRBD from controls....

Tonic REM sleep muscle activity is the strongest predictor of phenoconversion risk to neurodegenerative disease in isolated REM sleep behaviour disorder.

Previous studies have shown that rapid eye movement sleep without atonia during polysomnography can predict the risk of phenoconversion to neurodegenerative disease in patients with isolated rapid eye...

REM Sleep Behavior Disorder and Its Possible Prodromes in General Population: Prevalence, Polysomnography Findings, and Associated Factors.

To evaluate the prevalence of REM sleep behavior disorder (RBD) and its possible prodromal conditions, isolated dream enactment behavior (DEB) and isolated REM without atonia (RWA), in a general popul... From a population-based prospective cohort in Korea, 1,075 participants (age 60.1 ± 7.0 years; range 50-80 years; men 53.7%) completed the RBD screening questionnaire (RBDSQ), a structured telephone i... RBD was diagnosed in 20 participants, isolated RWA in 133 participants, and isolated DEB in 48 participants. Sex and DEB frequency-adjusted prevalence of RBD was 1.4% (95% CI 1.0%-1.8%), isolated RWA ... This study provides prevalence estimates of RBD and its possible prodromal conditions based on a structured telephone interview and RWA measurement on PSG from the general population....